Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant gets access to Metamorphic's technology:

This article was originally published in Clinica

Executive Summary

Guidant is to buy certain technology relating to the development of embolic protection devices from Metamorphic Surgical Devices, according to a 10Q filing submitted to the US Securities and Exchange Commission. If certain milestones are met, Guidant may pay up to $15 million in the fourth quarter and a further $3 million thereafter. Guidant, which is already active in this area, says the technological feasibility of the products has not yet been established. The devices are used to capture particles that become dislodged during vascular surgery that can cause stroke if left untreated.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074123

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel